No Evidence of Disease Clinical Trial
Official title:
Intervention to Promote Uptake of Cancer Risk Counseling for Underserved Latinas
This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.
PRIMARY OBJECTIVES: I. To conduct a randomized trial of a culturally-informed pre-genetic cancer risk assessment (GCRA) telephone intervention. II. To evaluate the effect of the pre-GCRA intervention versus a time and attention control versus standard scheduling procedure alone (usual care) on levels of anxiety, perceived personal control and cancer genetics knowledge. III. To explore patients' experiences with the pre-GCRA intervention through post-intervention telephone interviews. SECONDARY OBJECTIVES: I. To explore patients' perceived barriers to GCRA through no-show telephone interviews. OUTLINE: Patients are randomized to 1 of 3 treatment arms. ARM I: Patients receive a culturally-informed adapted motivational interviewing telephone call. ARM II: Patients participate in a controlled condition comprising a health habits intervention group. ARM III: Patients receive usual care comprising a standard scheduling phone call and proceed with normal GCRA process. All patients are mailed standard new patient packets containing questionnaires on demographics and personal health history, and a family history form. All patients then undergo genetic cancer risk assessment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03156309 -
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
|
Phase 1 | |
| Active, not recruiting |
NCT02780401 -
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
|
Phase 1 | |
| Completed |
NCT02099136 -
Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers
|
Phase 2 | |
| Completed |
NCT03725449 -
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
|
N/A | |
| Completed |
NCT01497431 -
Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants
|
Phase 1 | |
| Withdrawn |
NCT03120390 -
Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors
|
N/A | |
| Completed |
NCT02090933 -
Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers
|
Phase 2 | |
| Terminated |
NCT02735512 -
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
|
||
| Completed |
NCT01149096 -
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
|
Phase 3 | |
| Completed |
NCT02961790 -
Oxybutynin Chloride in Managing Hot Flashes
|
Phase 3 | |
| Completed |
NCT02288416 -
Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening
|
N/A | |
| Completed |
NCT01698294 -
Biomarkers in Post-Menopausal Women Receiving Flaxseed
|
N/A | |
| Completed |
NCT00896974 -
Study of 9cUAB30 in Healthy Participants
|
Phase 1 | |
| Terminated |
NCT03284346 -
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
|
N/A |